Literature DB >> 17697306

Disturbances in melatonin and core body temperature circadian rhythms after minimal invasive surgery.

I Gögenur1, B Middleton, V B Kristiansen, D J Skene, J Rosenberg.   

Abstract

BACKGROUND: Sleep disturbances, fatigue and reduced general well-being frequently occur after minimal invasive surgery. The circadian rhythms of melatonin and core body temperature are central to the regulation of normal sleep. The aim of this study was to assess changes in these circadian rhythms after laparoscopic cholecystectomy.
METHODS: Twelve women were studied before and after laparoscopic cholecystectomy. The major urinary melatonin metabolite, 6-sulphatoxymelatonin (aMT6s), and the core body temperature were measured for 1 day before and 1 day after surgery. The basal and maximum secretion of aMT6s were determined, as well as the timing and amplitude of aMT6s and the temperature rhythm. The patients' rest-activity and calculated sleep parameters were assessed by actigraphy.
RESULTS: A significant delay in the timing of aMT6s rhythm was observed after surgery [median (range) peak time of aMT6s: after surgery, 05:49 h (02:57-08:23 h); before surgery, 04:32 h (02:18-06:49 h); P< or = 0.05]. The amplitude of the aMT6s rhythm was also significantly decreased after surgery [after surgery, 7.1 ng aMT6s/mg creatinine (1-15.9 ng); before surgery, 13.2 ng aMT6s/mg creatinine (2.9-22.7 ng); P< or = 0.005]. There was almost a 12-h phase delay of the core body temperature rhythm after surgery [peak time: before surgery, 17:39 h (15:17-22:06 h); after surgery, 05:14 h (03:24-21:43 h); P< or = 0.01].
CONCLUSIONS: Following laparoscopic cholecystectomy, there was a delay in the timing of the aMT6s rhythm and a decreased evening decline in the temperature rhythm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697306     DOI: 10.1111/j.1399-6576.2007.01387.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

1.  Sleep and Anesthesia - Common mechanisms of action.

Authors:  Susana Vacas; Philip Kurien; Mervyn Maze
Journal:  Sleep Med Clin       Date:  2013-03

2.  Effects of surgery and general anaesthesia on sleep-wake timing: CLOCKS observational study.

Authors:  M L van Zuylen; A J G Meewisse; W Ten Hoope; W J Eshuis; M W Hollmann; B Preckel; S E Siegelaar; D J Stenvers; J Hermanides
Journal:  Anaesthesia       Date:  2021-08-21       Impact factor: 12.893

Review 3.  Actigraphy for measurement of sleep and sleep-wake rhythms in relation to surgery.

Authors:  Michael T Madsen; Jacob Rosenberg; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

4.  The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.

Authors:  Melissa Voigt Hansen; Michael Tvilling Madsen; Ida Hageman; Lars Simon Rasmussen; Susanne Bokmand; Jacob Rosenberg; Ismail Gögenur
Journal:  BMJ Open       Date:  2012-01-11       Impact factor: 2.692

5.  Melatonin and cortisol exhibit different circadian rhythm profiles during septic shock depending on timing of onset: a prospective observational study.

Authors:  Eleni N Sertaridou; Ioanna G Chouvarda; Konstantinos I Arvanitidis; Eirini K Filidou; George C Kolios; Ioannis N Pnevmatikos; Vasilios E Papaioannou
Journal:  Ann Intensive Care       Date:  2018-12-04       Impact factor: 6.925

6.  Effects of general versus regional anaesthesia on circadian melatonin rhythm and its association with postoperative delirium in elderly patients undergoing hip fracture surgery: study protocol for a prospective cohort clinical trial.

Authors:  Yi Yuan; Yanan Song; Wenchao Zhang; Zhengqian Li; Geng Wang; Yunyang Jia; Yang Zhou; Xinning Mi; Xixi Jia; Xiaoxiao Wang; Chang Liu; Yue Li; Chengmei Shi; Yongzheng Han; Xiangyang Guo
Journal:  BMJ Open       Date:  2021-02-12       Impact factor: 2.692

7.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.